• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register

VSV Molecular Switch

February 26, 2024

Vesicular stomatitis virus (VSV) is a disease that primarily effects horses, cattle, and swine. Humans can contract this disease by coming in contact with an infected animal. The disease is most often found in North America and Central America. In humans, the symptoms are similar to a flu. The virus replicates quickly and its genome is small and easy to manipulate. Because of this, it has become a useful research tool, as a vaccine platform, and as an oncolytic vector.

There are multiple methods in use to modify viruses such as this. The most important factor in controlling the virus and putting it to use is to have control over the viruses natural ability to replicate. One method to take control over replication is the use of intein splicing. Intein splicing is often a spontaneous biochemical reaction, however, previous research has developed inteins that only undergo splicing in the presence of 4-hydroxytamoxifen.

In vitro Testing

In this way, 4-hydroxytamoxifen can be used as a molecular switch to either prevent or allow splicing to occur. This idea was tested by a team of researchers at Beijing Institute of Biotechnology. After first screening for the most effective intein insertion site, the in vitro replication regulation of the modified virus was assessed. They confirmed that the presence or absence of 4-hydroxytamoxifen directly controlled the replication ability.

In vivo Testing

After seeing the positive results in vitro, they then continued the research in vivo. Laboratory mice were first injected intracerebrally with the modified virus and then also injected intraperitoneally with 4-hydroxytamoxifen. The progression of this experiment was measured using luminescence imaging of the brain. They confirmed that the virus was still controlled in vivo.

This is an exciting improvement in manipulating and controlling a virus so that it may be used as a tool in biological systems. The same idea applied to vesicular stomatitis virus may also be useful in working with various other viruses too.

4-Hydroxytamoxifen is available at LKT Labs:

(E/Z)-4-Hydroxytamoxifen

(E)-4-Hydroxytamoxifen

(Z)-4-Hydroxytamoxifen

Zhao Z, Wang B, Wu S, et al. Regulated control of virus replication by 4-hydroxytamoxifen-induced splicing. Front Microbiol. 2023 Mar 13:14:1112580. doi: 10.3389/fmicb.2023.1112580. PMID: 36992923

 

Tags: tamoxifen Categories: News

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only